We are live on ! Find out more
PRPH

ProPhase Labs
PRPH

Delisted

PRPH was delisted on the 2nd of January, 2026.

Back to rankings

16 hedge funds and large institutions have $1.58M invested in ProPhase Labs in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding

Funds holding: 14 → 16 (+2)

0.02% more ownership

Funds ownership: 0.44% → 0.46% (+0.02%)

4% less capital invested

Capital invested by funds: $1.65M → $1.58M (-$73K)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$30.4K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$30.3K
3
Renaissance Technologies
Renaissance Technologies
New York
+$4.83K
4
PAM
Panagora Asset Management
Massachusetts
+$302

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$7.27K
2
Deutsche Bank
Deutsche Bank
Germany
-$3.92K
3
Morgan Stanley
Morgan Stanley
New York
-$151
4
Bank of America
Bank of America
North Carolina
-$90

PRPH Hedge Fund Activity: Q3 2018 in Review

16 of the 4,390 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q3 2018, worth a combined $1.58M — down 4.4% from $1.65M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PRPH positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $30.4K. The largest seller was UBS Group, cutting an estimated $7.27K.

  • 16 institutional investors held ProPhase Labs (PRPH) as of Q3 2018, up from 14 in Q2 2018.
  • Funds reported $1.58M of ProPhase Labs stock for Q3 2018, down 4.4% quarter-over-quarter.
  • 2 funds opened new ProPhase Labs positions in Q3 2018 and 0 closed out, a net change of +2 holders.
  • The largest ProPhase Labs buyer in Q3 2018 was Susquehanna International Group, an estimated $30.4K added.
  • The largest ProPhase Labs seller in Q3 2018 was UBS Group, an estimated $7.27K sold.

Based on aggregated 13F filings for Q3 2018.